Evidence
Oncol Lett. 2023 Nov 27;27(1):36. doi: 10.3892/ol.2023.14169. eCollection 2024 Jan.
ABSTRACT
Glioma is the most prevalent type of brain tumor characterized by a poor 5-year survival rate and a high mortality rate. Malignant gliomas are commonly treated by surgery, chemotherapy and radiotherapy. However, due to toxicity and resistance to chemoradiotherapy, these treatments can be ineffective. Anxiety and depression are highly prevalent in patients with glioma, adversely affecting disease prognosis and posing societal concerns. Ferroptosis is a type of non-apoptotic, iron-dependent cell death characterized by the accumulation of lethal reactive oxygen species produced by iron metabolism, and it serves a key role in numerous diseases. Regulation of iron phagocytosis may serve as a therapeutic strategy for the development of novel glioma treatments. The present review discusses the mechanisms underlying the occurrence and regulation of ferroptosis, its role in the genesis and evolution of gliomas, and its association with glioma-related anxiety and depression. By exploring potential targets for glioma treatment, the present review provides a theoretical basis for the development of novel therapeutic strategies against glioma.
PMID:38108075 | PMC:PMC10722542 | DOI:10.3892/ol.2023.14169
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Research progress on ferroptosis in gliomas (Review)
🌐 90 Days
VR Related Evidence Matrix
- Fatty acid-binding protein 5 is a functional biomarker and indicator of ferroptosis in cerebral hypoxia
- Ferroptosis in organ ischemia-reperfusion injuries: recent advancements and strategies
- Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update
- Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update
- Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease
- Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
- Glioma
- Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas
- Fractionated radiation therapy alters energy metabolism and induces cellular quiescence exit in patient-derived orthotopic xenograft models of high-grade glioma
- Malignant glioma in L-2-Hydroxyglutaric Aciduria: thorough molecular characterization of a case and literature review
- Iron metabolism: backfire of cancer cell stemness and therapeutic modalities
- Mesenchymal stem cells as therapeutic vehicles for glioma
- SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis
- SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis
- Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
- Status epilepticus in patients with brain tumors and metastases: A multicenter cohort study of 208 patients and literature review
- Very Long-Term Survivorship in Pediatric DIPG: Case Report and Review of the Literature
- A guideline on the molecular ecosystem regulating ferroptosis
- Tanshinone _A inhibits ferroptosis via Nrf2 signaling pathway to protect liver in rats of non-alcoholic fatty liver disease
- Butylated Hydroxytoluene (BHT) Protects SH-SY5Y Neuroblastoma Cells from Ferroptotic Cell Death: Insights from In Vitro and In Vivo Studies
- Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas
- Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities
- CaMKII activity and metabolic imbalance-related neurological diseases: Focus on vascular dysfunction, synaptic plasticity, amyloid beta accumulation, and lipid metabolism
- The involvement of ROS-regulated programmed cell death in hepatocellular carcinoma
- Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/b-catenin pathway and acts as an onco-immunological biomarker
- Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model
- Electroacupuncture Inhibits Neural Ferroptosis in Rat Model of Traumatic Brain Injury via Activating System Xc-/GSH/GPX4 Axis
- Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study
- Ethanol-Induced Hepatic Ferroptosis Is Mediated by PERK-Dependent MAMs Formation: Preventive Role of Quercetin
- The Role of Oxidative Stress in Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Preclinical Studies
- Ferroptosis inhibitors reduce celastrol toxicity and preserve its insulin sensitizing effects in insulin resistant HepG2 cells
- An update on susceptibility-weighted imaging in brain gliomas
- Case of Hallervorden-Spatz Syndrome: A Tale of Twin Sisters
- Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile
- A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancer
- Integration analysis of cell division cycle-associated family genes revealed potential mechanisms of gliomagenesis and constructed an artificial intelligence-driven prognostic signature
- Erythropoietin hyporesponsiveness in non-alcoholic fatty liver disease
- End-to-End Multi-task Learning Architecture for Brain Tumor Analysis with Uncertainty Estimation in MRI Images
- Indoleamine 2,3-dioxygenase 1-mediated iron metabolism in macrophages contributes to lipid deposition in nonalcoholic steatohepatitis
- Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review)
- ROS-Induced Endothelial Dysfunction in the Pathogenesis of Atherosclerosis
- Copper enhances aggregational toxicity of mutant huntingtin in a Drosophila model of Huntington's Disease
- Progress in The Research of Lactate Metabolism Disruption And Astrocyte-Neuron Lactate Shuttle Impairment in Schizophrenia: A Comprehensive Review
- Is there a role for metastasis-directed therapy in bladder cancer?
- Changing practice to improve quality of life in glioma
- Investigating the role of circulating tumor cells in gastric cancer: a comprehensive systematic review and meta-analysis
- Single-Fraction Palliative High-Dose-Rate Brachytherapy for Symptom Management in a 97-Year-Old Patient With Dementia
- Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotype
- Alcohol Promotes Lipogenesis in Sebocytes-Implications for Acne
- Associations of Ultrasound Findings with Serum Iron and Ferritin Levels in Children with Obesity
- Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy
- Role of Angiotensin II in Non-Alcoholic Steatosis Development
- Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment
- DMT1 ubiquitination by Nedd4 protects against ferroptosis after intracerebral hemorrhage
- Mandatory fortification of rice in the public distribution system in India: An ethics perspective
- Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis
- Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter's syndrome
- Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review)
- The Role of Delirium on Short- and Long-Term Postoperative Outcomes Following Major Gastrointestinal Surgery for Cancer
- Metastatic pancreatic carcinoma with neuroendocrine differentiation in a cat
- Neurodegenerative effects of air pollutant Particles: Biological mechanisms implicated for Early-Onset Alzheimer's disease
- PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma
- Stereotactic radiosurgery for brain metastasis from cholangiocarcinoma
- Osteonal Damage Patterns from Ballistic and Blunt Force Trauma in Human Long Bones
Evidence Blueprint
Research progress on ferroptosis in gliomas (Review)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Research progress on ferroptosis in gliomas (Review)
🌐 365 Days
VR Related Evidence Matrix
- Dissecting the potential role of ferroptosis in liver diseases: an updated review
- Fatty acid-binding protein 5 is a functional biomarker and indicator of ferroptosis in cerebral hypoxia
- Striking a NRF2: The rusty and rancid vulnerabilities toward ferroptosis in Alzheimer's disease
- Iron chelation prevents nigrostriatal neurodegeneration in a chronic methamphetamine mice model
- Ferroptosis contributes to ethanol-induced hepatic cell death via labile iron accumulation and GPx4 inactivation
- Ferroptosis in organ ischemia-reperfusion injuries: recent advancements and strategies
- Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update
- Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update
- Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease
- Selective autophagy associated with iron overload aggravates non-alcoholic steatohepatitis via ferroptosis
- Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
- Glioma
- Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas
- Radiographic growth rate as a predictor of aggressiveness of diffuse gliomas without 1p19q codeletion
- Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma
- Fractionated radiation therapy alters energy metabolism and induces cellular quiescence exit in patient-derived orthotopic xenograft models of high-grade glioma
- Malignant glioma in L-2-Hydroxyglutaric Aciduria: thorough molecular characterization of a case and literature review
- A Novel Type of IDH Wild-type Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic Profile
- Iron metabolism: backfire of cancer cell stemness and therapeutic modalities
- Dynamic chromatin accessibility during nutritional iron overload reveals a BMP6-independent induction of cell cycle genes
- Melatonin Ameliorates Hepatic Ferroptosis in NAFLD by Inhibiting ER Stress via the MT2/cAMP/PKA/IRE1 Signaling Pathway
- Berberine ameliorates iron levels and ferroptosis in the brain of 3 × Tg-AD mice
- Mesenchymal stem cells as therapeutic vehicles for glioma
- Primary brain tumours in adults
- Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases
- Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD
- Association of MGMT Promotor Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating Chemotherapy
- SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis
- SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis
- European Cancer Organisation Essential Requirements for Quality Cancer Care: adult glioma
- Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
- Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas
- Status epilepticus in patients with brain tumors and metastases: A multicenter cohort study of 208 patients and literature review
- Very Long-Term Survivorship in Pediatric DIPG: Case Report and Review of the Literature
- Increased ferroptosis in leukocytes from preeclamptic women involving the long non-coding taurine upregulated gene 1 (TUG1)
- Risk factors for the in‑hospital and 1‑year mortality of elderly patients hospitalized due to COVID‑19‑related pneumonia
- A guideline on the molecular ecosystem regulating ferroptosis
- Tanshinone _A inhibits ferroptosis via Nrf2 signaling pathway to protect liver in rats of non-alcoholic fatty liver disease
- Concurrent gliomas in patients with multiple sclerosis
- Iron in multiple sclerosis - Neuropathology, immunology, and real-world considerations
- Tolerability of ifosfamide-containing regimen in patients with high-risk renal and INI-1-deficient tumors
- Butylated Hydroxytoluene (BHT) Protects SH-SY5Y Neuroblastoma Cells from Ferroptotic Cell Death: Insights from In Vitro and In Vivo Studies
- Reactive oxygen species (ROS)-mediated oxidative stress in chronic liver diseases and its mitigation by medicinal plants
- In vitro CRISPR screening uncovers CRTC3 as a regulator of IFN-γ-induced ferroptosis of hepatocellular carcinoma
- Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas
- Regulated Necrosis in Glaucoma: Focus on Ferroptosis and Pyroptosis
- Long-term outcomes of symptomatic optic pathway glioma: 32-year experience at a single Western Australian tertiary pediatric oncology center
- Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
- Epidemiology and survival of adult-type diffuse glioma in Belgium during the molecular era
- Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities
- CaMKII activity and metabolic imbalance-related neurological diseases: Focus on vascular dysfunction, synaptic plasticity, amyloid beta accumulation, and lipid metabolism
- Comprehensive profiling of stem-like features in pediatric glioma cell cultures and their relation to the subventricular zone
- MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells
- Low-Grade Gliomas: Histological Subtypes, Molecular Mechanisms, and Treatment Strategies
- Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in IDH mutant glioma
- Melatonin targets ferroptosis through bimodal alteration of redox environment and cellular pathways in NAFLD model
- The involvement of ROS-regulated programmed cell death in hepatocellular carcinoma
- An unusual presentation of bilateral optic pathway glioma in Crouzon Syndrome
- Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/b-catenin pathway and acts as an onco-immunological biomarker
- Design of Tetrazolium Cations for the Release of Antiproliferative Formazan Chelators in Mammalian Cells
- Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model
- Diffuse Midline Glioma Invasion and Metastasis Rely on Cell-autonomous Signaling
- Sestrin2 attenuates depressive-like behaviors and neuroinflammation in CUMS mice through inhibiting ferroptosis
- Electroacupuncture Inhibits Neural Ferroptosis in Rat Model of Traumatic Brain Injury via Activating System Xc-/GSH/GPX4 Axis